Hand foot syndrome associated with standard dose cytarabine

Hand-foot syndrome, is a side effect of cytotoxic chemotherapy, causes erythema, dysthesias, swelling of palms and soles and sometimes blisters. Rarely, it may ulcerate. The most commonly used drug that frequently causes this reaction is 5-fluorouracil or its prodrug oral capecitabine. High dose cyt...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Atul, Baghmar, Saphalta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Images in Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932608/
https://www.ncbi.nlm.nih.gov/pubmed/24604970
http://dx.doi.org/10.4103/0971-5851.125263
_version_ 1782304818292850688
author Sharma, Atul
Baghmar, Saphalta
author_facet Sharma, Atul
Baghmar, Saphalta
author_sort Sharma, Atul
collection PubMed
description Hand-foot syndrome, is a side effect of cytotoxic chemotherapy, causes erythema, dysthesias, swelling of palms and soles and sometimes blisters. Rarely, it may ulcerate. The most commonly used drug that frequently causes this reaction is 5-fluorouracil or its prodrug oral capecitabine. High dose cytarabine is known to cause HFS. Here we report a case of HFS caused by standard dose cytarabine.
format Online
Article
Text
id pubmed-3932608
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-39326082014-03-06 Hand foot syndrome associated with standard dose cytarabine Sharma, Atul Baghmar, Saphalta Indian J Med Paediatr Oncol Images in Oncology Hand-foot syndrome, is a side effect of cytotoxic chemotherapy, causes erythema, dysthesias, swelling of palms and soles and sometimes blisters. Rarely, it may ulcerate. The most commonly used drug that frequently causes this reaction is 5-fluorouracil or its prodrug oral capecitabine. High dose cytarabine is known to cause HFS. Here we report a case of HFS caused by standard dose cytarabine. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3932608/ /pubmed/24604970 http://dx.doi.org/10.4103/0971-5851.125263 Text en Copyright: © Indian Journal of Medical and Paediatric Oncology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Images in Oncology
Sharma, Atul
Baghmar, Saphalta
Hand foot syndrome associated with standard dose cytarabine
title Hand foot syndrome associated with standard dose cytarabine
title_full Hand foot syndrome associated with standard dose cytarabine
title_fullStr Hand foot syndrome associated with standard dose cytarabine
title_full_unstemmed Hand foot syndrome associated with standard dose cytarabine
title_short Hand foot syndrome associated with standard dose cytarabine
title_sort hand foot syndrome associated with standard dose cytarabine
topic Images in Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932608/
https://www.ncbi.nlm.nih.gov/pubmed/24604970
http://dx.doi.org/10.4103/0971-5851.125263
work_keys_str_mv AT sharmaatul handfootsyndromeassociatedwithstandarddosecytarabine
AT baghmarsaphalta handfootsyndromeassociatedwithstandarddosecytarabine

Ejemplares similares